MarketInOut Stock Screener Log In | Sign Up

Bioventix Plc

LSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Bioventix Plc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization106.85 mln
Float4.44 mln
Earnings Date03/29/2027

EPS

141
Exceptional

P / E

14.18
Fair value

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.68
Likely reliable

Relative Strength

98 / 100
Top performer

Debt / Equity

0.00
Debt-free

Business Description

Founded in 2003 and headquartered in Farnham, United Kingdom, Bioventix PLC develops and sells specialised sheep-derived antibodies used in medical diagnostic tests around the world. The company's products support testing across a wide range of health areas, including thyroid function, vitamin D levels, heart conditions, fertility, cancer, and drug use. Bioventix also offers testing solutions for measuring human exposure to industrial pollutants, including options that can be used outside of a laboratory setting. In addition, the company provides custom antibody development services and tools designed to speed up environmental and industrial health monitoring.

Key Fundamentals

EPS141
P/E14.18
ROE67.17
RPS2.48
ROIC118
ROA58.99
EBITDA, mln10.28
EV / EBITDA9.52
EV / EBIT9.58
Revenue, mln12.97
EV / Revenue7.55

Quote Details

Last 2,000.00
Change -25 (-1.23%)
Open 2,075.00
Volume 17,140
Turnover 34,280,000
Average Volume 18,664

Financial Ratios

Pre-Tax Profit Margin79
Leverage Ratio1.12
Current Ratio8.53
Price / Book9.11
Price / Tangible Book9.09
Price / Cash Flow13.20
Price / Free Cash Flow13.14
Debt / Equity0.00
Price / Sales8.13
PEG Ratio4.29

Financial Strength

Altman Z-Score49.48
Piotroski F-Score 6 / 9
Beneish M-Score-2.68
Price to Intrinsic Value1.27
Price to Graham Number2.36
Shiller PE Ratio12.69

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.96% 21 / 100   
1 Month 21.95% 98 / 100   
2 Months 34.23% 97 / 100   
6 Months 17.65% 87 / 100   
1 Year 5.12% 44 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog